{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:26:50Z","timestamp":1775024810554,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T00:00:00Z","timestamp":1308009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10096-011-1310-2","type":"journal-article","created":{"date-parts":[[2011,6,12]],"date-time":"2011-06-12T23:42:22Z","timestamp":1307922142000},"page":"295-301","source":"Crossref","is-referenced-by-count":25,"title":["Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia"],"prefix":"10.1007","volume":"31","author":[{"given":"M. S.","family":"Albur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bowker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MacGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,14]]},"reference":[{"key":"1310_CR1","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1128\/JCM.42.12.5650-5657.2004","volume":"42","author":"NA Mee-Marquet van der","year":"2004","unstructured":"van der Mee-Marquet NA, Domelier AS, Girard N, Quentin R (2004) Epidemiology and typing of S. aureus strains isolated from bloodstream infections. J Clin Microbiol 42:5650\u20135657","journal-title":"J Clin Microbiol"},{"key":"1310_CR2","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JCM.41.8.3655-3660.2003","volume":"41","author":"DJ Diekema","year":"2003","unstructured":"Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655\u20133660","journal-title":"J Clin Microbiol"},{"key":"1310_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.38834.421713.2F","volume":"333","author":"DH Wyllie","year":"2006","unstructured":"Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 333:281\u2013284","journal-title":"BMJ"},{"key":"1310_CR4","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","volume":"293","author":"VG Fowler Jr","year":"2005","unstructured":"Fowler VG Jr, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012\u20133021","journal-title":"JAMA"},{"key":"1310_CR5","unstructured":"Health Protection Agency (2010) Quarterly results from the mandatory surveillance of MRSA bacteraemia, June 2010 report. www.hpa.org.uk . Accessed 4 June 2011"},{"key":"1310_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perenceivich EN, Scwwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis 36:53\u201359","journal-title":"Clin Infect Dis"},{"key":"1310_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5694\/j.1326-5377.2001.tb143562.x","volume":"175","author":"M Whitby","year":"2001","unstructured":"Whitby M, McLaws M-L, Berry G (2001) Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175:264\u2013267","journal-title":"Med J Aust"},{"key":"1310_CR8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","volume":"110","author":"WR McCabe","year":"1962","unstructured":"McCabe WR, Jackson GG (1962) Gram-negative bacteremia, I: etiology and ecology. Arch Intern Med 110:847\u2013855","journal-title":"Arch Intern Med"},{"key":"1310_CR9","first-page":"M7","volume-title":"Methods for dilution susceptibility tests for bacteria that grow aerobically: approved standard","author":"Clinical Standards and Laboratory Standards Institute","year":"2006","unstructured":"Clinical Standards and Laboratory Standards Institute (2006) Methods for dilution susceptibility tests for bacteria that grow aerobically: approved standard, 7th edn. CLSI, Wayne, pp M7\u2013A7","edition":"7"},{"key":"1310_CR10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/38.6.1055","volume":"38","author":"KE Bowker","year":"1996","unstructured":"Bowker KE, Holt HA, Reeves DS, MacGowan AP (1996) Bactericidal activity, post-antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations. J Antimicrob Chemother 38:1055\u20131060","journal-title":"J Antimicrob Chemother"},{"key":"1310_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","volume":"47","author":"M Wootton","year":"2001","unstructured":"Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, McGowan AP et al (2001) A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. JAC 47:399\u2013403","journal-title":"JAC"},{"key":"1310_CR12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1469-0691.2005.01243.x","volume":"11","author":"S Monecke","year":"2005","unstructured":"Monecke S, Ehricht R (2005) Rapid genotyping of methicillin-resistant Staphylococcus aureus isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect 11:825\u2013833","journal-title":"Clin Microbiol Infect"},{"key":"1310_CR13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1469-0691.2006.01420.x","volume":"12","author":"S Monecke","year":"2006","unstructured":"Monecke S, Slickers P, Hotzel H et al (2006) Microarray-based characterisation of a Panton-Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 12:718\u2013728","journal-title":"Clin Microbiol Infect"},{"key":"1310_CR14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/374621","volume":"187","author":"KB Laupland","year":"2003","unstructured":"Laupland KB, Church DL, Mucenski M, Sutherland LR, Dele Davies H (2003) Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 187:1452\u20131459","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"1310_CR15","first-page":"339","volume":"46","author":"RG Corey","year":"2008","unstructured":"Corey RG, Karchmer AW, Bayer AS, Miller LG (2008) Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge. Clin Infect Dis 46(Suppl 5):339\u2013394","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1310_CR16","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","volume":"42","author":"G Sakoulas","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos M (2004) Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of MRSA bacteraemia. J Clin Microbiol 42(6):2398\u20132402","journal-title":"J Clin Microbiol"},{"key":"1310_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/dkm445","volume":"61","author":"PA Moise","year":"2008","unstructured":"Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A, Sakoulas G (2008) Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. JAC 61:85\u201390","journal-title":"JAC"},{"key":"1310_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J (2008) Influence of vancomycin MIC on the treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Clin Infect Dis 46:193\u2013200","journal-title":"Clin Infect Dis"},{"key":"1310_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer J, Moellering R, Criag W, Billeter M et al (2009) Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and Society of Infectious Diseases Pharmacists. Clin Infect Dis 49:325\u2013327","journal-title":"Clin Infect Dis"},{"key":"1310_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/520088","volume":"196","author":"VG Fowler","year":"2007","unstructured":"Fowler VG, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A et al (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196:738\u2013747","journal-title":"J Infect Dis"},{"issue":"2","key":"1310_CR21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","volume":"70","author":"S Jarraud","year":"2002","unstructured":"Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70(2):631\u2013641","journal-title":"Infect Immun"},{"key":"1310_CR22","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/IAI.68.8.4407-4415.2000","volume":"68","author":"RJ Williams","year":"2000","unstructured":"Williams RJ, Ward JM, Henderson B, Poole S, O\u2019Hara BP, Wilson M, Nair SP (2000) Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: Characterization of the prototypic gene and its protein product, set1. Infect Immun 68:4407\u20134415","journal-title":"Infect Immun"},{"key":"1310_CR23","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/IAI.72.7.4261-4270.2004","volume":"72","author":"AM Al-Shangiti","year":"2004","unstructured":"Al-Shangiti AM, Naylor CE, Nair SP, Briggs DC, Henderson B, Chain BM (2004) Structural relationships and cellular tropism of staphylococcal superantigen-like proteins. Infect Immun 72:4261\u20134270","journal-title":"Infect Immun"},{"key":"1310_CR24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2006.06.011","volume":"44","author":"SH Rooijakkers","year":"2007","unstructured":"Rooijakkers SH, van Strijp JA (2007) Bacterial complement evasion. Mol Immunol 44:23\u201332","journal-title":"Mol Immunol"},{"key":"1310_CR25","volume-title":"Staphylococcal superantigen-like protein 13 targets human endothelial cells. O.39 & P.108","author":"A Taylor","year":"2006","unstructured":"Taylor A, Basu I, Langley R, Angel C, Dunbar R, Fraser J (2006) Staphylococcal superantigen-like protein 13 targets human endothelial cells. O.39 & P.108. ISSSI, Maastricht"},{"key":"1310_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16-34.2000","volume":"13","author":"MM Dinges","year":"2000","unstructured":"Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16\u201334","journal-title":"Clin Microbiol Rev"},{"key":"1310_CR27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/605555","volume":"49","author":"H Ammerlaan","year":"2009","unstructured":"Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M et al (2009) Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries (SEPIA study group). Clin Infect Dis 49:997\u20131005","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1310-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1310-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T10:01:03Z","timestamp":1686132063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1310-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,14]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1310-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,14]]}}}